Literature DB >> 2497138

Comparative evaluation of mitogenicity and basement-membrane-degrading activity of Pseudomonas aeruginosa slime glycolipoprotein and alginate.

E D Anastassiou1, G Karakiulakis, E Missirlis, M E Maragoudakis, G Dimitracopoulos.   

Abstract

Alginate from a heavily mucoid Pseudomonas aeruginosa strain and slime glycolipoprotein obtained from the revertant nonmucoid variant of the mucoid strain were tested for mitogenic activity on human peripheral lymphocytes and for degradation of 3H-labeled basement membranes of the anterior lens capsule of bovine eyes. Slime glycolipoprotein exerted mitogenic activity in concentrations from 50 to 200 micrograms/ml, whereas alginate was not mitogenic as shown by [3H]thymidine uptake. Alginate did not show any basement membrane degradation, whereas slime glycolipoprotein exhibited basement-membrane-degrading activity from 35 to 450 micrograms/ml in a dose-related manner. This activity was inhibited by metal chelators but not thiol protease inhibitors. The results suggest that alginate lacks the mitogenic and biodegrading activities of slime glycolipoprotein; these activities nevertheless need further investigation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2497138      PMCID: PMC267345          DOI: 10.1128/jcm.27.3.490-494.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Basement membrane biosynthesis. Secretion without deposition of underhydroxylated basement membrane collagen by parietal yolk sacs.

Authors:  M E Maragoudakis; H J Kalinsky; J Wasvary
Journal:  Biochim Biophys Acta       Date:  1978-01-03

2.  Specific cleavage of human type III and IV collagens by Pseudomonas aeruginosa elastase.

Authors:  L W Heck; K Morihara; W B McRae; E J Miller
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

3.  A human lymphocyte mitogen extracted from the extracellular slime layer of Pseudomonas aeruginosa.

Authors:  M Papamichail; G Dimitracopoulos; G Tsokos; J Papavassiliou
Journal:  J Infect Dis       Date:  1980-05       Impact factor: 5.226

4.  The slime of Pseudomonas aeruginosa: biological characterization and possible role in experimental infection.

Authors:  J W Sensakovic; P F Bartell
Journal:  J Infect Dis       Date:  1974-02       Impact factor: 5.226

5.  Alginate production by clinical nonmucoid Pseudomonas aeruginosa strains.

Authors:  E D Anastassiou; A C Mintzas; C Kounavis; G Dimitracopoulos
Journal:  J Clin Microbiol       Date:  1987-04       Impact factor: 5.948

6.  Purification and characterization of a murine basement membrane collagen-degrading enzyme secreted by metastatic tumor cells.

Authors:  T Salo; L A Liotta; K Tryggvason
Journal:  J Biol Chem       Date:  1983-03-10       Impact factor: 5.157

7.  Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains.

Authors:  R E Hancock; L M Mutharia; L Chan; R P Darveau; D P Speert; G B Pier
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

8.  Effectiveness of immunization with multicomponent vaccines in protection against hemorrhagic pneumonia due to Pseudomonas aeruginosa infection in mink.

Authors:  J Y Homma; C Abe; R Yanagawa; H Noda
Journal:  Rev Infect Dis       Date:  1983 Nov-Dec

9.  Polyclonal B cell stimulation and interleukin 1 induction by the mucoid exopolysaccharide of Pseudomonas aeruginosa associated with cystic fibrosis.

Authors:  L Daley; G B Pier; J D Liporace; D D Eardley
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

10.  Slime glycolipoproteins and the pathogenicity of various strains of Pseudomonas aeruginosa in experimental infection.

Authors:  G Dimitracopoulos; P F Bartell
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.